Search Results - "Meersseman, W."

Refine Results
  1. 1
  2. 2

    Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study by Meersseman, W., Lagrou, K., Spriet, I., Maertens, J., Verbeken, E., Peetermans, W. E., Van Wijngaerden, E.

    Published in Intensive care medicine (01-09-2009)
    “…Purpose Recovery of Candida from the respiratory tract is common. Large series on the incidence of histologically proven Candida pneumonia in intensive care…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Optimization of the Cutoff Value for the Aspergillus Double-Sandwich Enzyme Immunoassay by Maertens, Johan A., Klont, Rocus, Masson, Christine, Theunissen, Koen, Meersseman, Wouter, Lagrou, Katrien, Heinen, Christine, Crépin, Brigitte, Eldere, Johan Van, Tabouret, Marc, Donnelly, J. Peter, Verweij, Paul E.

    Published in Clinical infectious diseases (15-05-2007)
    “…Background.Many health care centers worldwide use the Platelia Aspergillus enzyme immunoassay (PA-EIA; Bio-Rad Laboratories) for diagnosis of invasive…”
    Get full text
    Journal Article
  7. 7

    Primary syphilitic proctitis : case report and literature review by Struyve, M, Meersseman, W, Van Moerkercke, W

    Published in Acta gastro-enterologica belgica (01-07-2018)
    “…Rectal ulcerations are an uncommon presentation of a primary syphilis infection. Anorectal syphilis is difficult to diagnose because of its often asymptomatic…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Terminal Complement Pathway Deficiency in an Adult Patient with Meningococcal Sepsis by Staels, F., Meersseman, W., Stordeur, P., Willekens, K., Van Loo, S., Corveleyn, A., Meyts, I., Meyfroidt, G., Schrijvers, R.

    Published in Case reports in immunology (23-05-2022)
    “…The complement system is an essential part of our innate immune system. Three enzymatic activation pathways are described, all converging into a common…”
    Get full text
    Journal Article
  10. 10

    Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation by Spriet, Isabel, Annaert, Pieter, Meersseman, Philippe, Hermans, Greet, Meersseman, Wouter, Verbesselt, Rene, Willems, Ludo

    Published in Journal of antimicrobial chemotherapy (01-04-2009)
    “…Objectives During extracorporeal membrane oxygenation (ECMO), drug disposition changes significantly. Plasma concentrations are altered due to an expanded…”
    Get full text
    Journal Article
  11. 11

    Treatment of chronic respiratory failure in kyphoscoliosis: oxygen or ventilation? by Buyse, B, Meersseman, W, Demedts, M

    Published in The European respiratory journal (01-09-2003)
    “…Patients with kyposcoliosis and chronic respiratory insufficiency are treated either with home oxygen therapy or ventilation. Kyphoscoliotic patients…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Elderly versus nonelderly patients with invasive aspergillosis in the ICU: a comparison and risk factor analysis for mortality from the AspICU cohort by Matthaiou, D K, Dimopoulos, G, Taccone, F S, Bulpa, P, Van den Abeele, A M, Misset, B, Meersseman, W, Spapen, H, Cardoso, T, Charles, P E, Vogelaers, D, Blot, S

    Published in Medical mycology (Oxford) (01-08-2018)
    “…Data regarding the epidemiology and diagnosis of invasive aspergillosis in the critically ill population are limited, with data regarding elderly patients (≥75…”
    Get full text
    Journal Article Web Resource
  14. 14
  15. 15

    Whipple's disease in a man of North African descent : case report and brief review of the literature by Lenfant, M, Callemeyn, J, Alaerts, H, Meersseman, W, Van Moerkercke, W

    Published in Acta gastro-enterologica belgica (01-01-2019)
    “…A 62-year-old man of North African descent presented with weight loss in the past year and diarrhea for three weeks. His medical history included erosive…”
    Get more information
    Journal Article
  16. 16

    Hyperhomocysteinemia: a trigger for complement-mediated TMA? by Bernards, J, Doubel, P, Meeus, G, Lerut, E, Corveleyn, A, Van Den Heuvel, L P, Meersseman, W, Kuypers, D K, Claes, K J

    Published in Acta clinica belgica (English ed. Online) (01-02-2021)
    “…A 34-year-old man of North African descent was referred to the emergency department because of malignant hypertension (220/113 mmHg), acute visual disturbances…”
    Get full text
    Journal Article
  17. 17

    Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures by Paiva, J.A., Mergulhão, P., Gomes, A., Taccone, F.S., Van den Abeele, A.-M., Bulpa, P., Misset, B., Meersseman, W., Dimopoulos, G., Rello, J., Vogelaers, D., Blot, S.

    “…•Diagnosis of invasive pulmonary aspergillosis (IPA) in critically ill patients is challenging.•Diagnostic and treatment decisions appear to be based on…”
    Get full text
    Journal Article Web Resource
  18. 18
  19. 19

    Epidemiology of mucormycosis: review of 18 cases in a tertiary care hospital by Saegeman, V., Maertens, J., Ectors, N., Meersseman, W., Lagrou, K.

    Published in Medical mycology (Oxford) (01-03-2010)
    “…Mucormycosis is an angio-invasive mycosis with high morbidity and mortality rates which mainly affects immunocompromised patients. It is no longer an uncommon…”
    Get full text
    Journal Article
  20. 20

    Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients by Ruhnke, M., Paiva, J.A., Meersseman, W., Pachl, J., Grigoras, I., Sganga, G., Menichetti, F., Montravers, P., Auzinger, G., Dimopoulos, G., Borges Sà, M., Miller, P.J., Marĉek, T., Kantecki, M.

    Published in Clinical microbiology and infection (01-07-2012)
    “…A prospective, multicentre, phase Illb study with an exploratory, open-label design was conducted to evaluate efficacy and safety of anidulafungin for the…”
    Get full text
    Journal Article